Loading…

Identification of Prognostic and Predictive Osteosarcoma Biomarkers

Both adolescents and children suffer from osteosarcoma, localized in the metaphysis of the long bones. This is the most common primary high-grade bone tumor in this patient group. Early tumor detection is the key to ensuring effective treatment. Improved osteosarcoma outcomes in clinical trials have...

Full description

Saved in:

Bibliographic Details
Published in:	Medical sciences (Basel) 2019-02, Vol.7 (2), p.28
Main Authors:	Zamborsky, Radoslav, Kokavec, Milan, Harsanyi, Stefan, Danisovic, Lubos
Format:	Article
Language:	English
Subjects:	Antibodies Biomarkers Bone cancer Cancer therapies Cell cycle Chemotherapy Clinical trials Cytokines DNA methylation Gene expression Growth factors malignant bone tumors Medical prognosis Metastasis MicroRNAs osteosarcoma Pediatrics Review Stem cells treatment
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c3968-aba6749c77007d18977eed22c43ae28a206d842b2bd34fa33c2f9ba6bccbeec23
cites	cdi_FETCH-LOGICAL-c3968-aba6749c77007d18977eed22c43ae28a206d842b2bd34fa33c2f9ba6bccbeec23
container_end_page
container_issue	2
container_start_page	28
container_title	Medical sciences (Basel)
container_volume	7
creator	Zamborsky, Radoslav Kokavec, Milan Harsanyi, Stefan Danisovic, Lubos
description	Both adolescents and children suffer from osteosarcoma, localized in the metaphysis of the long bones. This is the most common primary high-grade bone tumor in this patient group. Early tumor detection is the key to ensuring effective treatment. Improved osteosarcoma outcomes in clinical trials have been contingent on biomarker discovery and an evolving understanding of molecules and their complex interactions. In this review, we present a short overview of biomarkers for osteosarcoma, and highlight advances in osteosarcoma-related biomarker research. Many studies show that several biomarkers undergo critical changes with osteosarcoma progression. Growing knowledge about osteosarcoma-related markers is expected to positively impact the development of therapeutics for osteosarcoma, and ultimately of clinical care. It has also become important to develop new biomarkers, which can identify vulnerable patients who should be treated with more intensive and aggressive therapy after diagnosis.
doi_str_mv	10.3390/medsci7020028
format	article
fullrecord	<record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4a13cd4f17f2490c9ce1462a46ac4af3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4a13cd4f17f2490c9ce1462a46ac4af3</doaj_id><sourcerecordid>2548810619</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3968-aba6749c77007d18977eed22c43ae28a206d842b2bd34fa33c2f9ba6bccbeec23</originalsourceid><addsrcrecordid>eNpdUctOHDEQHKFEARGOuUYj5ZLLEL92bF8iJas8VkIiBzhbPe324s3smNizSPw9JksQGx_8rC5XVzXNO87OpbTs05Z8waiZYEyYo-ZEMN13Umj-6sX-uDkrZcPqsFyaBXvTHEumF0ozedIsV56mOYaIMMc0tSm0v3JaT6nMEVuYfD2SjzjHO2ovy0ypQMa0hfZrrHP-Tbm8bV4HGAudPa2nzfX3b1fLn93F5Y_V8stFh9L2poMBeq0sas2Y9txYrYm8EKgkkDAgWO-NEoMYvFQBpEQRbK0ZEAciFPK0We15fYKNu82x_n_vEkT39yLltYNcZY_kFHCJXgWug1CWoUXiqhegekAFQVauz3uu291QXcRqQobxgPTwZYo3bp3uXK844-ZRzMcngpz-7KjMbhsL0jjCRGlXnKiZaC1qlxX64T_oJu3yVK1yYqGM4azntqK6PQpzKiVTeBbDmXtM2x2kXfHvX3bwjP6XrXwATs6m2A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548810619</pqid></control><display><type>article</type><title>Identification of Prognostic and Predictive Osteosarcoma Biomarkers</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Zamborsky, Radoslav ; Kokavec, Milan ; Harsanyi, Stefan ; Danisovic, Lubos</creator><creatorcontrib>Zamborsky, Radoslav ; Kokavec, Milan ; Harsanyi, Stefan ; Danisovic, Lubos</creatorcontrib><description>Both adolescents and children suffer from osteosarcoma, localized in the metaphysis of the long bones. This is the most common primary high-grade bone tumor in this patient group. Early tumor detection is the key to ensuring effective treatment. Improved osteosarcoma outcomes in clinical trials have been contingent on biomarker discovery and an evolving understanding of molecules and their complex interactions. In this review, we present a short overview of biomarkers for osteosarcoma, and highlight advances in osteosarcoma-related biomarker research. Many studies show that several biomarkers undergo critical changes with osteosarcoma progression. Growing knowledge about osteosarcoma-related markers is expected to positively impact the development of therapeutics for osteosarcoma, and ultimately of clinical care. It has also become important to develop new biomarkers, which can identify vulnerable patients who should be treated with more intensive and aggressive therapy after diagnosis.</description><identifier>ISSN: 2076-3271</identifier><identifier>EISSN: 2076-3271</identifier><identifier>DOI: 10.3390/medsci7020028</identifier><identifier>PMID: 30754703</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antibodies ; Biomarkers ; Bone cancer ; Cancer therapies ; Cell cycle ; Chemotherapy ; Clinical trials ; Cytokines ; DNA methylation ; Gene expression ; Growth factors ; malignant bone tumors ; Medical prognosis ; Metastasis ; MicroRNAs ; osteosarcoma ; Pediatrics ; Review ; Stem cells ; treatment</subject><ispartof>Medical sciences (Basel), 2019-02, Vol.7 (2), p.28</ispartof><rights>2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3968-aba6749c77007d18977eed22c43ae28a206d842b2bd34fa33c2f9ba6bccbeec23</citedby><cites>FETCH-LOGICAL-c3968-aba6749c77007d18977eed22c43ae28a206d842b2bd34fa33c2f9ba6bccbeec23</cites><orcidid>0000-0002-5074-9621</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2548810619/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2548810619?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30754703$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zamborsky, Radoslav</creatorcontrib><creatorcontrib>Kokavec, Milan</creatorcontrib><creatorcontrib>Harsanyi, Stefan</creatorcontrib><creatorcontrib>Danisovic, Lubos</creatorcontrib><title>Identification of Prognostic and Predictive Osteosarcoma Biomarkers</title><title>Medical sciences (Basel)</title><addtitle>Med Sci (Basel)</addtitle><description>Both adolescents and children suffer from osteosarcoma, localized in the metaphysis of the long bones. This is the most common primary high-grade bone tumor in this patient group. Early tumor detection is the key to ensuring effective treatment. Improved osteosarcoma outcomes in clinical trials have been contingent on biomarker discovery and an evolving understanding of molecules and their complex interactions. In this review, we present a short overview of biomarkers for osteosarcoma, and highlight advances in osteosarcoma-related biomarker research. Many studies show that several biomarkers undergo critical changes with osteosarcoma progression. Growing knowledge about osteosarcoma-related markers is expected to positively impact the development of therapeutics for osteosarcoma, and ultimately of clinical care. It has also become important to develop new biomarkers, which can identify vulnerable patients who should be treated with more intensive and aggressive therapy after diagnosis.</description><subject>Antibodies</subject><subject>Biomarkers</subject><subject>Bone cancer</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Chemotherapy</subject><subject>Clinical trials</subject><subject>Cytokines</subject><subject>DNA methylation</subject><subject>Gene expression</subject><subject>Growth factors</subject><subject>malignant bone tumors</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>MicroRNAs</subject><subject>osteosarcoma</subject><subject>Pediatrics</subject><subject>Review</subject><subject>Stem cells</subject><subject>treatment</subject><issn>2076-3271</issn><issn>2076-3271</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdUctOHDEQHKFEARGOuUYj5ZLLEL92bF8iJas8VkIiBzhbPe324s3smNizSPw9JksQGx_8rC5XVzXNO87OpbTs05Z8waiZYEyYo-ZEMN13Umj-6sX-uDkrZcPqsFyaBXvTHEumF0ozedIsV56mOYaIMMc0tSm0v3JaT6nMEVuYfD2SjzjHO2ovy0ypQMa0hfZrrHP-Tbm8bV4HGAudPa2nzfX3b1fLn93F5Y_V8stFh9L2poMBeq0sas2Y9txYrYm8EKgkkDAgWO-NEoMYvFQBpEQRbK0ZEAciFPK0We15fYKNu82x_n_vEkT39yLltYNcZY_kFHCJXgWug1CWoUXiqhegekAFQVauz3uu291QXcRqQobxgPTwZYo3bp3uXK844-ZRzMcngpz-7KjMbhsL0jjCRGlXnKiZaC1qlxX64T_oJu3yVK1yYqGM4azntqK6PQpzKiVTeBbDmXtM2x2kXfHvX3bwjP6XrXwATs6m2A</recordid><startdate>20190211</startdate><enddate>20190211</enddate><creator>Zamborsky, Radoslav</creator><creator>Kokavec, Milan</creator><creator>Harsanyi, Stefan</creator><creator>Danisovic, Lubos</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5074-9621</orcidid></search><sort><creationdate>20190211</creationdate><title>Identification of Prognostic and Predictive Osteosarcoma Biomarkers</title><author>Zamborsky, Radoslav ; Kokavec, Milan ; Harsanyi, Stefan ; Danisovic, Lubos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3968-aba6749c77007d18977eed22c43ae28a206d842b2bd34fa33c2f9ba6bccbeec23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antibodies</topic><topic>Biomarkers</topic><topic>Bone cancer</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Chemotherapy</topic><topic>Clinical trials</topic><topic>Cytokines</topic><topic>DNA methylation</topic><topic>Gene expression</topic><topic>Growth factors</topic><topic>malignant bone tumors</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>MicroRNAs</topic><topic>osteosarcoma</topic><topic>Pediatrics</topic><topic>Review</topic><topic>Stem cells</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zamborsky, Radoslav</creatorcontrib><creatorcontrib>Kokavec, Milan</creatorcontrib><creatorcontrib>Harsanyi, Stefan</creatorcontrib><creatorcontrib>Danisovic, Lubos</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Medical sciences (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zamborsky, Radoslav</au><au>Kokavec, Milan</au><au>Harsanyi, Stefan</au><au>Danisovic, Lubos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of Prognostic and Predictive Osteosarcoma Biomarkers</atitle><jtitle>Medical sciences (Basel)</jtitle><addtitle>Med Sci (Basel)</addtitle><date>2019-02-11</date><risdate>2019</risdate><volume>7</volume><issue>2</issue><spage>28</spage><pages>28-</pages><issn>2076-3271</issn><eissn>2076-3271</eissn><abstract>Both adolescents and children suffer from osteosarcoma, localized in the metaphysis of the long bones. This is the most common primary high-grade bone tumor in this patient group. Early tumor detection is the key to ensuring effective treatment. Improved osteosarcoma outcomes in clinical trials have been contingent on biomarker discovery and an evolving understanding of molecules and their complex interactions. In this review, we present a short overview of biomarkers for osteosarcoma, and highlight advances in osteosarcoma-related biomarker research. Many studies show that several biomarkers undergo critical changes with osteosarcoma progression. Growing knowledge about osteosarcoma-related markers is expected to positively impact the development of therapeutics for osteosarcoma, and ultimately of clinical care. It has also become important to develop new biomarkers, which can identify vulnerable patients who should be treated with more intensive and aggressive therapy after diagnosis.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>30754703</pmid><doi>10.3390/medsci7020028</doi><orcidid>https://orcid.org/0000-0002-5074-9621</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 2076-3271
ispartof	Medical sciences (Basel), 2019-02, Vol.7 (2), p.28
issn	2076-3271 2076-3271
language	eng
recordid	cdi_doaj_primary_oai_doaj_org_article_4a13cd4f17f2490c9ce1462a46ac4af3
source	Open Access: PubMed Central; Publicly Available Content Database
subjects	Antibodies Biomarkers Bone cancer Cancer therapies Cell cycle Chemotherapy Clinical trials Cytokines DNA methylation Gene expression Growth factors malignant bone tumors Medical prognosis Metastasis MicroRNAs osteosarcoma Pediatrics Review Stem cells treatment
title	Identification of Prognostic and Predictive Osteosarcoma Biomarkers
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A58%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20Prognostic%20and%20Predictive%20Osteosarcoma%20Biomarkers&rft.jtitle=Medical%20sciences%20(Basel)&rft.au=Zamborsky,%20Radoslav&rft.date=2019-02-11&rft.volume=7&rft.issue=2&rft.spage=28&rft.pages=28-&rft.issn=2076-3271&rft.eissn=2076-3271&rft_id=info:doi/10.3390/medsci7020028&rft_dat=%3Cproquest_doaj_%3E2548810619%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3968-aba6749c77007d18977eed22c43ae28a206d842b2bd34fa33c2f9ba6bccbeec23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2548810619&rft_id=info:pmid/30754703&rfr_iscdi=true